Elevance Health Inc (ELV)
Industry Healthcare Plans
This stock can be held in an Investment ISA and an Investment Account
Sell
$357.00
Buy
$361.02
$-1.15 (-0.32%)
Prices updated at 13 Dec 2025, 00:58 EST
| Prices minimum 15 mins delay
Prices in USD
Anthem Inc is a health benefits company offering a network-based managed care plans to the large and small employer, individual, Medicaid and Medicare markets. Its business segments are Commercial and Specialty Business, Government Business and Other.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 171,340m | 176,810m | |
| - | - | |
| - | - | |
| - | - | |
| 5,987m | 5,980m | |
| - | - | |
| Sales, General and administrative | - | - |
| Interest expenses | 1,030m | 1,185m |
| Provision for income taxes | 1,724m | 1,933m |
| Operating expenses | - | - |
| Income before taxes | 7,715m | 7,904m |
| Net income available to common shareholders | 5,987m | 5,980m |
| 25.38 | 25.81 | |
| Net interest income | -1,030m | -1,185m |
| Advertising and promotion | - | - |
| Net investment income, net | 420m | 472m |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 25.22 | 25.68 |
| Free cash flow per share | 34.5274 | 3.7206 |
| Book value/share | 164.8553 | 192.4348 |
| Debt equity ratio | 0.591411 | 0.707201 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | - | - |
| Current liabilities | - | - |
| Total capital | 62,552m | 70,533m |
| Total debt | 25,120m | 31,232m |
| Total equity | 39,306m | 41,315m |
| Total non current liabilities | - | - |
| Loans | 23,246m | 29,218m |
| Total assets | 108,928m | 116,889m |
| Total liabilities | - | - |
| Cash and cash equivalents | 6,526m | 8,288m |
| Common stock | 233m | 227m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 7,387m | 6,526m |
| Cash dividends paid | -1,395m | -1,508m |
| 6,765m | 4,552m | |
| Investments (gains) losses | -5,572m | -5,167m |
| 6,526m | 8,288m | |
| Net income | - | - |
| 8,061m | 5,808m | |
| -1,296m | -1,256m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.